News Focus
News Focus
icon url

Kurt_Banoffee

07/06/19 10:59 AM

#75111 RE: drugmanrx #75110

Like I said, folk here like semantics when it suits them and don't when it don't. Sure, it's commercial revenue, I said as much in the post that got you all worked up, but it's not recurring revenue which is the revenue that matters for this stock because that's the revenue that proves the technology.

Folks here also like to read things that weren't written, I never said anything like I "believe the buyers of the reactor will NEVER EVER USE THEM." I said they have not demonstrated that they can produce commercially viable product.

Hopefully it will all work as planned and royalties will flow quickly. If it was a sure thing, the stock would not be $0.03 however.
icon url

TedJ

07/07/19 5:51 PM

#75162 RE: drugmanrx #75110

"The question is did or did not QTMM make a profit just selling the reactors?"

QMC was paid $500K per reactor by Atomtonics.

In early 2015, the same reactor from Access2Flow cost QMC $480K per the 2015 10-K.

Property and Equipment

Property and equipment increased $480,113 during the year ended June 30, 2015 due to the purchase of a second microreactor.



The question now is who built the latest reactors? The Accesss2Flow website http://www.access2flow.com/ seems to be inactive.